Prelude Therapeutics Inc. (PRLD): Price and Financial Metrics


Prelude Therapeutics Inc. (PRLD): $5.52

0.37 (+7.18%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PRLD Stock Price Chart Interactive Chart >

Price chart for PRLD

PRLD Price/Volume Stats

Current price $5.52 52-week high $43.55
Prev. close $5.15 52-week low $3.87
Day low $5.20 Volume 106,500
Day high $5.79 Avg. volume 264,169
50-day MA $4.71 Dividend yield N/A
200-day MA $11.21 Market Cap 263.28M

Prelude Therapeutics Inc. (PRLD) Company Bio


Prelude Therapeutics, Inc. operates as a cancer drug discovery company. It focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Gopi Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.


PRLD Latest News Stream


Event/Time News Detail
Loading, please wait...

PRLD Latest Social Stream


Loading social stream, please wait...

View Full PRLD Social Stream

Latest PRLD News From Around the Web

Below are the latest news stories about Prelude Therapeutics Inc that investors may wish to consider to help them evaluate PRLD as an investment opportunity.

Prelude Therapeutics to Present at the H.C. Wainwright BioConnect Virtual Conference

WILMINGTON, Del., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Prelude Therapeutics Inc. (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced that Kris Vaddi, PhD, Chief Executive Officer, will present at the H.C Wainwright BioConnect Virtual Conference, being held on January 10-13, 2022. The prerecorded presentation will become available on Monday, January 10, 2022 at 7:00 am ET and can be accessed by visiting the “Investors” page under the “Events & Presentation” section of the Pr

Yahoo | January 4, 2022

Orbimed Advisors Llc Buys Adagio Therapeutics Inc, Zimmer Biomet Holdings Inc, Biogen Inc, ...

New York, NY, based Investment company Orbimed Advisors Llc (Current Portfolio) buys Adagio Therapeutics Inc, Zimmer Biomet Holdings Inc, Biogen Inc, HCA Healthcare Inc, Erasca Inc, sells Prelude Therapeutics Inc, Aurinia Pharmaceuticals Inc, Ascendis Pharma A/S, Natera Inc, Anthem Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Orbimed Advisors Llc.

Yahoo | December 24, 2021

The 10 Most Shorted Stocks Right Now for Friday, Dec. 17

Shorted stocks continue to be of interest to retail traders looking for the next big day trade and we're diving into some top candidates!

William White on InvestorPlace | December 17, 2021

In spite of Prelude Therapeutics Incorporated's recent pullback, insiders still gained about US$12k after buying earlier this year.

Insiders who bought Prelude Therapeutics Incorporated ( NASDAQ:PRLD ) stock lover the last 12 months are probably not...

Yahoo | December 16, 2021

Prelude Therapeutics Inc (PRLD) EVP, Head of Chemistry Andrew Combs Bought $94,880 of Shares

EVP, Head of Chemistry of Prelude Therapeutics Inc (30-Year Financial, Insider Trades) Andrew Combs (insider trades) bought 8,000 shares of PRLD on 12/14/2021 at an average price of $11.86 a share.

Yahoo | December 16, 2021

Read More 'PRLD' Stories Here

PRLD Price Returns

1-mo 15.48%
3-mo -16.11%
6-mo -45.07%
1-year -79.33%
3-year N/A
5-year N/A
YTD -55.66%
2021 -82.60%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5242 seconds.